|
|
Office Locations:
|
349 Newbury Street, 2nd Floor
Boston, MA 02115
Phone: 970-759-6000
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Formed in 2023, Cure Ventures is an investment management firm, which invests through venture capital fund vehicles. The investment team intends to originate, found, and build cutting-edge, disruptive, start-up companies that develop novel medicines which target high unmet medical needs. The team is focused exclusively on founding and investing in companies that develop new therapeutics born from ground-breaking biotechnology research.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
